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The effects of cholesterol on the ion-channel function
of the Torpedo acetylcholine receptor (nAChR) and the
novel lipid-exposed gain in function C418W mutation
have been investigated in Xenopus laevis oocytes. We
found conditions to increase the cholesterol/phospho-
lipid (C/P) molar ratio on the plasma membrane of Xe-
nopus oocytes from 0.5 to 0.87, without significant phys-
ical damage or change in morphology to the oocytes. In
addition, we developed conditions to deplete endoge-
nous cholesterol from oocytes using a methyl--cyclo-
dextrin incubation procedure without causing mem-
brane instability of the cells. Methyl--cyclodextrin was
also used to examine the reversibility of the inhibitory
effect of cholesterol on AChR function. Depletion of 43%
of endogenous cholesterol from oocytes (C/P  0.3) did
not show any significant change in macroscopic re-
sponse of the wild type, whereas in the C418W mutant
the same cholesterol depletion caused a dramatic gain-
in-function response of this lipid-exposed mutation in
addition to the increased response caused by the muta-
tion itself. Increasing the C/P ratio to 0.87 caused an
inhibition of the macroscopic response of the Torpedo
wild type of about 52%, whereas the C418W mutation
showed an 81% inhibition compared with the responses
of control oocytes. The wild type receptor did not re-
cover from this inhibition when the excess cholesterol
was depleted to near normal C/P ratios; however, the
C418W mutant displayed 63% of the original current,
which indicates that the inhibition of this lipid-exposed
mutant was significantly reversed. The ability of the
C418W mutation to recover from the inhibition caused
by cholesterol enrichment suggests that the interaction
of cholesterol with this lipid-exposed mutation is signif-
icantly different from that of the wild type. The present
data demonstrate that a single lipid-exposed position in
the AChR could alter the modulatory effect of choles-
terol on AChR function.
The nicotinic acetylcholine receptor (nAChR)
1 from muscle
and electric ray organ is an integral membrane protein com-
prised of four homologous polypeptide subunits in a stoichiom-
etry of 2 (for review see Refs. 1–6). A consensus model for
the nAChR topology deduced from hydrophobicity profiles for
protein sequences obtained from cDNA sequences indicates
that each subunit contains at least four membrane-spanning
regions denoted M1 through M4 with both N and C termini
located on the extracellular side (7). This integral membrane
protein has been extensively used for the study of lipid-protein
interactions.
Previous biophysical studies of the nAChR used cholesterol
as a probe for the study of lipid-protein interactions. Most of
the information available on the sensitivity of the nAChR to the
lipid environment was obtained using reconstituted mem-
branes of purified Torpedo californica AChR. However, despite
a wealth of experimental data from reconstituted systems, the
role of membrane cholesterol in regulating AChR function has
not been completely elucidated, and some of the results have
remained controversial and sometimes even contradictory. The
contradictory results in the literature regarding the specific
lipid requirements of the nAChR may reflect a variety of con-
ditions, including the fact that the functional status of the
nAChR in most cases was performed in reconstituted mem-
branes with the additional lipid of interest tested at a molar
percentage of the total membrane lipids different from the
natural membranes. The relative level of a given lipid may be
the key factor in determining the fraction of AChR in a func-
tional conformation as well as the kinetics of the conforma-
tional change.
In reconstituted membranes, the ability of the nAChR to
conduct cations across the membrane and to undergo confor-
mational transitions from the resting to the desensitized state
(R f D) has been shown to be very sensitive to the lipid
composition (8–10). The mechanism by which lipid modulates
the ability of nAChR to undergo an agonist-induced conforma-
tional change remains unclear. A previous proposal suggested
the possibility that cholesterol regulation of membrane fluidity
might play a key role in the modulation of AChR function (9);
however, subsequent work challenged the fluidity hypothesis
(11, 12). A recent Fourier transform infrared study using re-
constituted membranes of purified nAChR raised the fluidity
hypothesis again (13). This study proposed that the membrane
fluidity modulates the relative population of nAChRs in the
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 resting and desensitized states. The data from reconstitution
experiments demonstrated that cholesterol interacts at some
discrete class of binding sites on the receptor (14, 15). Recently,
the binding sites for cholesterol at the protein interface of the
Torpedo nAChR were mapped using a novel photoreactive an-
alog of cholesterol (
125I-azido-cholesterol) (16). This study
found that cholesterol-binding sites were exclusive to the alpha
M4 and M1 and gamma M4 transmembrane segments. The
binding kinetics of ethidium bromide to the reconstituted Tor-
pedo nobiliana nAChR suggest that in the absence of choles-
terol the receptor is “locked” in the R conformation (17, 18).
Rankin and coworkers (17) showed that the number of nAChRs
that open in response to high agonist concentrations increase
with the percentage of cholesterol in the bilayer, reaching a
maximum at 30 mol% of cholesterol. This value corresponds to
a C/P molar ratio of about 0.42 that is slightly lower than the
molar ratio that we found in the Xenopus oocyte plasmatic
membrane.
In the present work we manipulate the cholesterol/phospho-
lipid molar ratios in the oocyte membrane to reach higher
membrane cholesterol levels (C/P  0.87) than the ratios stud-
ied in the reconstituted system. We also depleted endogenous
cholesterol from oocytes to reach C/P molar ratios similar to the
ones previously examined in the reconstituted system. The
voltage clamp technique was used to examine the effect of
cholesterol on T. californica nAChR function, including the
effect on a novel lipid-exposed C418W mutation that has been
shown to increase the macroscopic response (19–21). Our data
show that the interaction of cholesterol with Torpedo wild type
is remarkably different from the interaction with the C418W
mutant. These results raise the importance of the functional
role of lipid-protein interactions in ion-channel function and
underscore the importance of cysteine 418 in the  subunit of
the Torpedo nAChR in the modulatory action of cholesterol.
This approach will open a new dimension for studying lipid
effects on ion-channel function.
EXPERIMENTAL PROCEDURES
Confocal Imaging—The time course of cholesterol incorporation into
oocytes was monitored using a fluorescent cholesterol analog (22-(N-(7-
nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-23,24-bisnor-5-cholen-3-ol; Mo-
lecular Probes, Eugene, OR) and a Bio-Rad MRC-600 confocal system,
coupled to a Nikon Diaphot inverted microscope equipped with a 20
objective (numerical aperture  0.5, Olympus). This cholesterol analog
was excited with the 469-nm line of a Kr/Ar laser while its emission was
monitored through one of the two acquisition channels of the MRC-600
using the appropriate set of filters.
Isolation of the Plasma Membranes—The isolation of the plasma
membranes of the oocyte was accomplished according to a procedure as
described previously (22) with minor modifications. The vitelline mem-
branes of 15 oocytes were removed manually, and a homogenate was
layered on top of a 0.5 volume of 1.5 M sucrose (in 20 mM Tris-HCl, pH
7.6, 10 mM MgCl2,5 0m M KCl, 2 mM 2-mercaptoethanol, 1 mM EGTA,
0.1 mM phenylmethylsulfonyl fluoride) and centrifuged. The fatty layer
was discarded, the membranes were retrieved from the interface be-
tween the two layers, diluted with 4 volumes of buffer B (5.0 mM Hepes,
pH 7.4, 0.16 M NaCl, 0.1 mM phenylmethylsulfonyl fluoride), and pel-
leted at 16,000  g 10 min, at 4 °C. Cholesterol/phospholipid (C/P)
molar ratio of the plasmatic membrane of the oocyte was estimated
using protocols as described (23, 24).
Preparation of Cholesterol-enriched Liposomes—Liposomes were pre-
pared using the detergent removal technique and a Mini Lipoprep
(Amika Corp. catalog number S81110D). A solution containing choles-
terol/phosphatidylcholine/cholate at a molar ratio 1:1:2 was prepared in
chloroform. The mixed micelles formed spontaneously when lipids and
detergent deposited from the organic solvent are exposed to the MOR2
buffer. A lipid:detergent molar ratio of 0.8 was used, and the exposure
of lipids to the aqueous solvent was performed above the transition
temperature of the lipids. Subsequently, detergent removal was accom-
plished at constant temperature using the Mini-Lipoprep-Dialyzer (vol-
ume capacity 1.0 ml) and a DIACHEMA membrane (10.1 molecular
weight cut-off 10,000, high permeability). The resulting unilamellar
liposomes are well-defined tailored vesicles in the diameter size range
of 50–200 nm.
Estimation of C/P Molar Ratios in the Plasma Membrane of Oo-
cytes—Briefly, ten sample of 50 l containing the plasma membrane are
dried using nitrogen gas. Five of the samples were used for the choles-
terol molar estimation, and the other five were used for the phospho-
lipid molar estimation. For the cholesterol concentration, the five sam-
ples were resuspended in 50 l of Infinity cholesterol reagent (Sigma
Chemical Co., St. Louis, MO, catalog number 40125p) and incubated at
37 °C for 5 min. The cholesterol concentration (milligrams/dl) of the
samples was estimated by spectrophotometry at 501 nm. For the phos-
pholipid concentration, the samples are resuspended in 50 lo ft h e
saponification solution (2.0 M KOH in methanol) and incubated at room
temperature for 2 h. After the incubation 500 l of the molybdenum
solution was added (1 ml of 5% molybdenum, 3 ml of 15% ascorbic acid,
6 ml of dephosphorylated water) and incubated at 50 °C for 10 min. The
phospholipid concentration was estimated by spectrophotometry at 820
nm. The cholesterol:phospholipid molar ratio of the plasma membrane
of oocytes was estimated using the methods as described (23, 24).
Cholesterol Depletion Experiments in Intact Oocytes—Cholesterol de-
pletion in oocytes was accomplished using the procedure as described
previously (25) with some modifications. Briefly, oocytes were incu-
bated in 300 lo f5 0M methyl--cyclodextrin for 45 min and then
washed three times with a total volume of 3 ml of MOR2. This water-
soluble cyclic oligosaccharide has a high affinity for cholesterol and has
been heavily used as an effective tool for the transport of cholesterol
away from the cell surface (26). We used these protocols to deplete
endogenous cholesterol from oocytes and also to remove a fractional
amount of the excess of cholesterol after enrichment.
Cholesterol Enrichments Protocol—Cholesterol was incorporated into
Xenopus oocytes in a reversible manner as follows. The oocytes were
incubated in a solution containing cholesterol-enriched liposomes at
room temperature for 45 min. The incubated oocytes were then washed
three times with a total volume of 3 ml of MOR2. The cholesterol/
phospholipid (C/P) molar ratio of the plasma membrane of the oocytes
was estimated using protocols as described (23, 24) with minor modifi-
cation as described (27, 28). This method increased the cholesterol
phospholipid molar ratio of plasma membrane of the oocyte from 0.51 
0.1 (control) to 0.87  0.06 (n  90 oocytes in six batches of oocytes). The
average percentage of enrichment was 71%, and the C/P molar ratios of
the enriched oocytes were in the range 0.78–0.97.
Depletion of Cholesterol-enriched Oocytes—Oocytes expressing
wild type or the C418W mutant were perfused with 100 M ACh and
then exposed to a 45-min period of cholesterol enrichment. After
cholesterol enrichment, oocytes were voltage-clamped, and the mac-
roscopic response was assessed again with 100 M ACh (another
experimental protocol was to perform a dose-response curve 1–300 M
ACh). Subsequently, oocytes were exposed to methyl--cyclodextrin
(50 M) for 45 min and then washed three times with 3 ml of MOR2,
voltage-clamped, and perfused with 100 M ACh. Control experi-
ments were performed following the same protocols using MOR2
without methyl--cyclodextrin.
Expression in X. laevis Oocytes—RNA transcripts were synthesized
in vitro as described previously (19). The RNA transcripts (10 ng/oocyte
at the concentration of 0.2 g/l) of , , , and  subunit at a 2:1:1:1
ratios were injected into Xenopus oocytes.
Voltage Clamping—ACh-induced currents were recorded with a two-
electrode voltage clamp 3–5 days after mRNA injection with the Gene
Clamp 500 amplifier (Axon Instruments, Foster City, CA). Electrodes
were filled with 3 M KCl and had resistance of less than 2 M. Impaled
oocytes in the recording chamber were perfused at a rate of 0.5 ml/s
with MOR2 buffer (115 mM NaCl, 2.5 mM KCl, 5 mM MgCl2,1m M
Na2HPO4,5m M HEPES, 0.2 mM CaCl2, pH 7.4). ACh solutions were
made from calcium-free MOR2 to avoid activation of an endogenous
Ca
2-dependent Cl
 current (29, 30). For dose-response curves, each
oocyte was held at a membrane potential of 70 mV. Membrane cur-
rents were digitized at 0.5–2 kHz and filtered at 0.1 kHz using a TL-1
interface (Axon Instruments) and acquired by Whole Cell Program 3.2.1
software (kindly provided by Dr. John Demspter) running on a Pentium
III-based computer. Prisma version 3.0 (GraphPad, San Diego, CA)
software was utilized for data analysis and fitting. Dose-response data
were collected from peak currents at six ACh concentrations in the
range of 1.0 to 300 M. The data were fit using a curve of the form Y 
100/[1  (EC50/A)
n] and non-linear regression curves. The EC50 values
for individual oocytes were averaged to generate final estimates.
Cholesterol and Acetylcholine Receptor 46524
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 RESULTS
We began our study of the effects of cholesterol on the func-
tion of the acetylcholine receptor by developing a strategy to
dynamically change the cholesterol levels in the surface of X.
laevis oocytes. We took advantage of a recently developed flu-
orescent cholesterol analog (22-(N-(7-nitrobenz-2-oxa-1,3-dia-
zol-4-yl)amino)-23,24-bisnor-5-cholen-3-ol) to monitor choles-
terol incorporation into the surface membrane of cells following
the incubation with cholesterol-enriched liposomes using a con-
focal microscope (Fig. 1). An important consideration in these
studies was to significantly enrich the surface membrane of
cells without altering intracellular cholesterol concentration. A
series of confocal sections of an oocyte exposed to the liposomes
containing the cholesterol fluorescent analog are shown in Fig.
1( left). We found that under our controlled conditions choles-
terol was preferentially incorporated into the plasma mem-
brane (Fig. 1, right). Using this approach we estimated the
approximate time of liposome exposure required to reach a
cholesterol to phospholipid molar ratio (C/P) of 0.87.
Cholesterol Enrichment and AChR Function—The cholester-
ol/phospholipid molar ratio of the plasma membrane of oocytes
was in the range of 0.33–0.62 in seven batches of oocytes
tested, and the mean value obtained was 0.51  0.10 (Fig. 2).
However, there seems to be variability in the C/P molar ratio
that appears to be seasonal. As shown in Fig. 2, the enrichment
produced oocytes with a C/P molar ratio in the order of 0.87.
This C/P molar ratio is higher than the molar ratios reported in
reconstitution experiments of the T. californica AChR (17). The
resting membrane potential of the oocytes was only modestly
affected during the 45-min period of cholesterol enrichment
(Fig. 3A). The shift in membrane potential was overcome by
voltage-clamping oocytes at 70 mV for measuring nAChR
currents. The moderate hyperpolarization observed during the
first 15 min could be caused by an inhibitory effect of choles-
terol on the membrane-bound pumps, which are responsible for
the upkeep of the underlying ionic gradients. Interestingly, we
observed that in almost all the cholesterol-enriched oocytes,
exposure to methyl--cyclodextrin restored the membrane po-
tential by inducing a hyperpolarization that was in the range of
5t o20 mV. Thus, under the conditions that we used,
cholesterol seems to play a modulatory role in maintaining the
resting membrane potential of the oocyte. Fig. 4A shows three
typical experimental results in which an oocyte was voltage-
FIG.1 .Cholesterol enrichment in the plasma membrane of X. laevis oocytes monitored with confocal imaging. Image reconstruction
of 32 sequential confocal images showing incorporation of a fluorescent cholesterol analog (22-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-23,24-
bisnor-5-cholen-3-ol) to the surface of a X. laevis oocyte. Liposomes containing the fluorescent cholesterol analog (inside yellow circles) are shown
fusing with the plasma membrane (left). In the insert, 4 of a total of 32 sections are shown (right). Images were acquired using a Bio-Rad MRC 600
confocal microscope coupled to a Nikon Diaphot inverted microscope using a 20 objective (numerical aperture  0.5; Olympus). Confocal sections
were taken at intervals of 10 m. Note that if one focuses the confocal microscope toward the center of the cell, a donut-like fluorescent pattern
characteristic of fluorophores targeted to the plasma membrane could be observed. Indeed, from plots of the fluorescence intensity along the dotted
line in the middle panel it is clear that the fluorescence is restricted to the surface membrane. Note, however, that the spatial profile of this
membrane-associated fluorophore depends on the thickness of each confocal section. As the thickness of the section is increased, more out-of-focus
fluorescence will contribute to the collected image. Thus, the thickness of the fluorescence intensity profile (left-most panel) could give the
impression to the reader that the membrane at this section is thicker than it actually is.
FIG.2 .Estimation of cholesterol/phospholipid (C/P) molar ra-
tios. For each experiment 15 oocytes were used. For the control oocytes
the calculated C/P molar ratio average in seven experiments (n  105
oocytes) was 0.51. After cholesterol enrichment the C/P molar ratio
average was 0.87 (six experiments, n  90 oocytes). For cholesterol-
depleted oocytes the C/P molar ratio had an average of 0.3 (four exper-
iments, n  60 oocytes). In oocytes that were incubated with methyl-
-cyclodextrin after cholesterol enrichment, there was a reduction of
0.12 in the C/P molar ratio with a final average of 0.75. Note that the
differences were calculated based on the evaluation of the control
oocytes.
FIG.3 . Membrane potential changes during cholesterol en-
richment or depletion. Membrane potential was monitored during 45
min of cholesterol enrichment (A) or cholesterol depletion (B); (n  3
oocytes in both cases). During cholesterol enrichment the membrane
potential shifted with a biphasic behavior. First a moderate decrease in
the range of 10–15 mV during the first 15 min was followed by a slow
membrane repolarization (A). Cholesterol depletion caused a moderate
decrease in the membrane potential of oocytes during the first 15 min of
methyl--cyclodextrin exposure that was in the range of 10–15 mV.
After 20 min of methyl--cyclodextrin exposure, the oocytes gradually
recovered their membrane potential (B).
Cholesterol and Acetylcholine Receptor 46525
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 clamped at 70 mV and perfused with 100 M acetylcholine
(ACh) before (left) and after (right) cholesterol enrichment. In
cholesterol-enriched oocytes (C/P  0.87) the Torpedo wild type
AChR displays a macroscopic current inhibition of about 51.5%
(n  20) compared with the control oocytes. Fig. 4C shows the
same experiment for the lipid-exposed mutation C418W, and
the same cholesterol enrichment protocol leads to a 80.5%
inhibition (n  16 oocytes) for this mutation. This result indi-
cates that the functional response of the C418W is more
sensitive to the presence of higher levels of cholesterol in the
plasma membrane than the wild type. Fig. 4B represents an
average of the response of control oocytes that were incubated
in MOR2 only for the 45 min of incubation (i.e. no added
cholesterol present). The macroscopic current was recorded at
70 mV with 100 M ACh as in the enriched oocyte. This
control was performed to subtract the current that appears in
the absence of cholesterol that might be due to an apparent
gain-in-function due to the assembly of new surface nAChRs.
As shown in Fig. 4 (B and D) the negative percentage of inhi-
bition of the macroscopic response represents an increase in the
current. This means that, after exposing the oocyte for the first
time to ACh, there is a very small increase in the wild type
response (2%) response whereas in the C418W the response is
higher (33%) than for the wild type. If the C418W produced a
higher response after the first exposure to ACh, this suggests
that the inhibition of this mutation could be even higher than
the 80.5% detected in our protocol. Fig. 5A shows a family of
macroscopic currents from oocytes expressing the C418W mu-
tant before (left) and after cholesterol enrichment (right). The
dose-response curves for the control and cholesterol-enriched
oocytes expressing the C418W are shown in Fig. 5B. From the
reduction in the macroscopic response, it is clear that choles-
terol produced a substantial inhibitory response for the
C418W, however; the EC50 for ACh seems to be similar after
the enrichment. Fig. 5C shows a family of macroscopic currents
for an oocyte expressing wild type before (left) and after cho-
lesterol enrichment (right). The dose-response curves for the
normal and cholesterol-enriched oocytes expressing wild type
are shown in Fig. 5D. The EC50 values for the inhibited state in
the cholesterol-enriched oocyte appear to be similar to the
FIG.4 .Cholesterol enrichment produces an inhibitory response of the AChR. A and C, representative current traces of three different
oocytes for the wild type (WT) and the mutant C418W, before and after cholesterol enrichment. The oocytes were perfused with 100 M ACh and
incubated with cholesterol liposomes for 45 min. After the incubation, oocytes were washed three times with 1 ml of MOR2 and perfused again with
100 M ACh. In both cases there was an inhibition of the macroscopic response after cholesterol enrichment; this inhibition was more dramatic in
the mutant C418W. B and D, average percentages of inhibition of WT and C418W AChR after cholesterol enrichment. There was a 51.5% of
inhibition of WT (n  20) and 80.5% on the C418W (n  16). In both cases the controls were oocytes that were incubated with MOR2 for 45 min
instead of the cholesterol-enriched liposome.
Cholesterol and Acetylcholine Receptor 46526
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 control experiments for wild type and the C418W, suggesting
that the loss in functional response could be due to a reduction
in the number of resting nAChR rather than an inhibitory
effect on the ion-channel function. To estimate the overall
reduction in the macroscopic response, ACh-induced currents
of cholesterol-enriched oocytes were normalized to the equiva-
lent maximum current of control oocytes. As shown in Fig. 5E,
after cholesterol enrichment, the wild type displayed a fraction
of 0.62 of the original current at the highest ACh concentration
used, whereas for the C418W mutant only about 0.1 of the
original current was detected after the enrichment.
Cholesterol Depletion Experiments—These experiments were
designed to examine the functional response of the Torpedo
wild type and C418W mutant in a reduced cholesterol envi-
ronment. The resting membrane potential and the physical
condition of oocytes were not affected during the methyl--
cyclodextrin incubation period. During cholesterol depletion we
observed a moderate hyperpolarization in the membrane po-
tential of oocytes during the first 15 min that was in the range
of 10–15 mV. However, after 25 min the potential gradually
recovered (Fig. 3B). After the depletion protocol, oocytes
showed C/P molar ratios in the range of 0.19–0.44; the average
C/P obtained in 11 batches of oocytes tested was 0.3  0.1 (n 
60 oocytes tested) as shown in Fig. 2. Oocytes expressing wild
type and the C418W mutant were perfused with 100 M ACh
and then exposed to methyl--cyclodextrin (50 M) in MOR2 for
45 min. Immediately after incubation oocytes were washed,
voltage-clamped, and perfused with 100 M ACh. Macroscopic
currents from a representative experiment are shown in Fig. 6
(A–D). Fig. 6A shows one control experiment in which an oocyte
is voltage-clamped at 70 mV and perfused with 100 M ACh
(left) to give a macroscopic current. It was then perfused with
MOR2 for 5 min (with no ACh), incubated in MOR2 for 45 min
and afterward voltage-clamped again under the same condi-
tions (right). In Fig. 6B an oocyte expressing the wild type
nAChR was voltage-clamped at 70 mV and perfused with 100
M ACh (left) to give a macroscopic current. Then it was per-
fused with MOR2 for 5 min (with no ACh) and exposed to
methyl--cyclodextrin for 45 min and voltage-clamped again
under the same conditions (70 mV, 100 M ACh) (right). As
shown in Fig. 6E, exposure of an oocyte expressing the wild
type AChR to methyl--cyclodextrin, which leads to a range
between 17 and 46% with an average of 43% of decrease in the
plasma membrane cholesterol levels (C/P  0.3), does not seem
to affect the wild type. Fig. 6 (C and D) shows the same
experiments, including the control (C) for oocytes expressing
the C418W mutant. As shown in Fig. 6D, the C418W shows
a significant increase in macroscopic response after the deple-
tion protocol. It is remarkable that this increase in macroscopic
current response is caused by a single amino acid replacement
at the lipid protein interface. Fig. 6F shows the average re-
sponse of cholesterol depletion experiments for the C418W
mutant and its relation to control experiments. To estimate the
net increase in the macroscopic response after cholesterol de-
pletion, we estimated the difference between the potentiation
in macroscopic response between the experimental and control
oocytes. For the wild type the difference is less than 5%
whereas for the C418W mutant the potentiation effect is 67%.
To further characterize the effect of cholesterol depletion on
nAChR function we constructed dose-responses curves before
and after cholesterol depletion experiments (Fig. 7). After cho-
lesterol depletion, the dose-response curve of the wild type
FIG.5 .Cholesterol enrichment does not affect the EC50 of the AChR. Families of macroscopic current traces for the C418W and WT
before and after cholesterol enrichment are shown in A and C, respectively. The ACh concentrations used for the generation of the family of
currents were 1.0, 3.0, 10, 30, 100, and 300 M. Oocytes were clamped at 70 mV. After cholesterol enrichment (C/P  0.87) the dose-response
curves for the C418W (B) and WT (D) remain similar to the control. The EC50 of the C418W (n  3) was 2.7  0.6 M before and 2.3  0.1 M
after cholesterol enrichment. For the WT (n  3) the EC50 was 22.6  0.2 M before and 27.2  0.5 M after cholesterol enrichment. ACh-induced
currents of the cholesterol-enriched oocytes (right currents) are normalized to the equivalent ACh-induced currents previous to the cholesterol
enrichment (left current traces). Data from three to six different oocytes were normalized to provide a statistical average of the decrease in
macroscopic response for the WT and C418W mutant (E).
Cholesterol and Acetylcholine Receptor 46527
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 remains very similar to that of the control (Fig. 7A), suggesting
that a reduced number of channels, rather than inhibition of
the channel gating mechanism, caused the observed effects.
The average EC50 value of the control oocytes expressing wild
type AChR before and after depletion was 23 and 18 M, re-
spectively (n  4 oocytes). In contrast, the EC50 of the C418W
shifted from 4.2 M (control) to 0.9 M (n  5 oocytes) after
cholesterol depletion (Fig. 7B). The experimental data strongly
suggest that cholesterol depletion did not produce any signifi-
cant effects on the Torpedo wild type, whereas in a cholesterol-
depleted environment the C418W mutation displayed a sig-
nificant gain in function response.
Cholesterol Enrichment and Depletion—These experiments
were designed to examine if the inhibition detected in choles-
terol enrichment experiments could be reversed by treating the
oocytes with methyl--cyclodextrin. Oocytes expressing wild
type or the C418W mutation were perfused with 100 M ACh
and then exposed to cholesterol enrichment. The macroscopic
response was assessed using voltage clamping with 100 M
ACh immediately after cholesterol enrichment (C/P  0.87).
Methyl--cyclodextrin (50 M) in MOR2 was applied for 45 min
after which the macroscopic response was measured at 100 M
ACh (Fig. 8). We estimate that this protocol removes 14% of the
excess cholesterol (Fig. 2) and the C/P molar ratio was 0.75,
higher than in a control oocyte (C/P  0.51). Typical macro-
scopic currents obtained from these experiments for the wild
type and C418W mutant are shown in Fig. 8, A and B, respec-
tively. Cholesterol enrichment reduced the wild type response
by 79.7% (n  8), and after a 14% depletion there was no
significant change in the macroscopic response of the wild type.
The same treatment in the C418W mutant reduced the mac-
roscopic current by 62.3% (n  12), but after cholesterol deple-
tion (Fig. 8B), 63% of the original current was recovered.
DISCUSSION
Previous biophysical studies of the nAChR used cholesterol
as a probe for the study of lipid-protein interactions. In this
study we examined the functional response of the T. californica
AChR in different cholesterol environments in Xenopus oo-
cytes. To assess the role of protein-lipid interactions on the
AChR function, we used the novel lipid-exposed C418W mu-
tation that is located at the center of the M4 transmembrane
segment of the alpha subunit (Fig. 9). The M4 is the most
hydrophobic among the four membrane-spanning domains of
the nAChR and has the lowest level of side-chain conservation.
Photoaffinity labeling experiments have shown that M4 has
the largest number of lipid-exposed residues (31), and the pat-
tern of 3-trifluoromethyl-3-m-[
125I]iodophenyldiazirine label-
ing on the M4 domain is compatible with an  helical structure
(32). We have shown that tryptophan substitutions at this
FIG.6 .Cholesterol depletion produces an increase of the macroscopic response. Current traces were recorded at 100 M ACh, 70mV
before (left) and after (right) 45 min of methyl--cyclodextrin exposure. In oocytes expressing wild type AChR (A and B), the average current after
cholesterol depletion increased by 6.6%, as estimated from the difference between the experimental and control oocyte values (cholesterol-depleted
8.6–2.0% control; n  11) (E). In oocytes expressing the C418W AChR (C and D), the average current after cholesterol depletion was 66% (100%
cholesterol-depleted 34% control; n  22) (F). Note that the increase of macroscopic response is more dramatic in the mutant C418W. The C/P
molar ratio in control oocytes is 0.51 and 0.30 in the cholesterol-depleted oocytes.
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 postulated lipid-exposed C418 position of the nAChR could
produce a dramatic reduction in the closing transition of the
internal ion channel leading to a dramatic gain-in-function
response (19–21, 33). These studies raised the hypothesis that
a unique interaction of the tryptophan side chain at the lipid
interface of the receptor might alter nAChR function. In this
study we examined the functional effect of cholesterol on this
novel lipid-exposed mutation.
Numerous studies of lipid effects on the nAChR structure
and function have demonstrated that membrane lipid compo-
sition can modulate receptor function (5, 27, 34–37). However,
few studies have examined the effect of cholesterol on AChR
function in an intact cell membrane (26, 27, and 38). The aim of
this study was to measure the role of cholesterol on nAChR
function with particular attention to lipid-protein interactions
without compromising the physical state of the oocyte. The
significant changes in the C/P molar ratios that we produced in
the oocyte could represent a state of abnormal cholesterol levels
in a natural cell membrane.
Cholesterol Enrichment and AChR Function—When the C/P
molar ratio of an oocyte was increased to about 0.87, the mac-
roscopic response of the Torpedo wild type was reduced to 51%
(see Fig. 4). In contrast, the C418W mutant displayed a
higher state of inhibition: 81% of the macroscopic response was
inhibited by cholesterol enrichment. It is remarkable that a
single amino acid replacement in a lipid-exposed position of a
membrane protein that has twenty transmembrane domains
could produce such an increase in the sensitivity to levels of
cholesterol in the membrane. These results suggest that re-
placement of a tryptophan side chain at position C418 in-
creased the sensitivity of the nAChR function to the inhibitory
effect of cholesterol.
Previous experiments in reconstituted Torpedo nAChR have
demonstrated that the number of nAChRs that open in re-
sponse to high agonist concentrations increases with the per-
centage of cholesterol in the bilayer, reaching a maximum at
30% molar cholesterol (17). This value corresponds to a C/P
molar ratio of about 0.42, which is slightly lower than the molar
ratio of Xenopus oocyte plasma membrane (C/P  0.51). The
C/P molar ratios reached after cholesterol enrichment in the
oocyte membrane are much higher than those used in the
studies of reconstituted Torpedo nAChR. Therefore, the state of
inhibition that we observed at C/P molar ratios  0.87 in the
wild type does not challenge the data from the reconstitution
system. The higher C/P molar ratio range that we reached in
oocytes suggests that the functional response of the Torpedo
wild type in response to the membrane cholesterol levels or
“bulk fluidity” might have a bell-shaped profile. The substitu-
tion of a tryptophan side chain at the C418 position results in
a displacement of this bell-shaped profile to lower C/P molar
ratios, which leads to a loss-in-function response.
Cholesterol Depletion and AChR Function—The aim of these
experiments was to examine the functional response of the
nAChR in a reduced cholesterol environment, which presum-
ably leads to a state of higher membrane fluidity. We depleted
moderate cholesterol amounts from oocyte membranes to reach
C/P molar ratios of 0.3 after 45 min of incubation. Under these
conditions, Torpedo wild type exhibited no significant change
in macroscopic response (Fig. 6, A, B, and E). This result was
predictable because, as previously mentioned, the maximum
response of the reconstituted Torpedo reached an optimal value
at C/P molar ratios of 0.42. Therefore, at a C/P value of 0.3, the
functional response of the Torpedo in reconstituted membrane
is in its rising phase. In contrast, the same cholesterol deple-
tion level produced a dramatic increase in the macroscopic
response of the novel C418W mutation (Fig. 6, C, D, and F)
and a significant reduction in the EC50, from 4.2 to 0.9 M after
cholesterol depletion (Fig. 7B). These results raised several
questions: Why does a lipid-exposed mutation produce activa-
tion after cholesterol depletion? Does cholesterol depletion
cause an increase in the open channel probability of the
C418W or an increase in the active pool of AChRs in the
plasma membrane? What types of interactions govern this
increase in current response of the C418W after cholesterol
depletion?
Cholesterol Enrichment and Depletion—The aim of these
experiments was to investigate whether the inhibition caused
by cholesterol enrichment could be reversed. After recording
the current in the cholesterol-enriched state (C/P  0.87), the
oocyte was submitted to the depletion protocol. This depletion
removed a small fraction of the excess cholesterol (14%). The
average C/P molar ratio on these oocytes was 0.75, which is
somewhat higher than in the normal oocyte (0.51). The current
traces in Fig. 8A corresponding to Torpedo wild type showed no
reversion of the inhibition. In contrast, identical experiments
in oocytes expressing the C418W mutation showed a signifi-
cant recovery from inhibition (Fig. 8B). The recovery of the
C418W mutation after depleting a significant fraction of the
excess cholesterol demonstrates that the interaction of this
mutation with cholesterol is remarkably different from the wild
type.
The role of cholesterol in modulating the dynamic properties
of the lipid bilayer has been extensively studied, however, its
role in lipid-protein interactions is less well understood. In
FIG.7 .Cholesterol depletion reduced the C418W EC50. The
ACh concentrations used for the generation of dose-response curves
were 1.0, 3.0, 10, 30, 100, and 300 M ACh at 70 mV. After cholesterol
depletion (C/P  0.3) the dose-response curve of the WT (A) remains
very similar to the control (23.0  0.5 M to 18.0  0.8 M; n  4). In
contrast, the EC50 of the C418W (B) shifted from 4.2  0.3 M (control)
to 0.9  0.1 M after this moderate cholesterol depletion (n  5).
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 FIG.9 . Molecular model of the al-
pha-M4 transmembrane domain of
the T. californica AChR as an -heli-
cal structure. The localization of posi-
tion C418 in the M4 transmembrane
segment is shown in a lateral and top
view for the wild type (left) and the
C418W mutant (right). The volume of
positions C418 and C418W are repre-
sented with green and blue density,
respectively.
FIG.8 .The C418W mutant recovers from inhibition by cholesterol. Oocytes expressing wild type (top)( A) and the C418W mutant (B)
were first perfused with 100 M ACh (at 70 mV) and then exposed to a 45-min period of cholesterol enrichment followed by 45 min of cyclodextrin
exposure. The amount of current in nanoamps for each step is indicated below the macroscopic current trace. The percentage of the initial response
after cholesterol enrichment (C/P  0.87) ( Chol bar) for WT was 20.4% (n  8) (C) and 37.8% for the C418W mutant (n  12) (D). After depletion
of a fraction of the overloaded cholesterol, the average C/P ratio of the oocytes tested was 0.75. The WT did not recover (26.1% of the original current
(n  8, Chol  CD in C) from the inhibition by cholesterol whereas the C418W mutation recovered 63% of the original current (n  12, Chol 
CD in D) after this moderated cholesterol depletion. Control experiments in the absence of CD showed some degree of recuperation for the C418W
that was not observed for wild type.
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 reconstituted membranes, the ability of the Torpedo nAChR to
conduct cations across the membrane and undergo conforma-
tional transitions, from the resting to the desensitized state (R
f D), is very sensitive to the lipid composition (8–10, 13, 17,
18, 39). When Torpedo nAChR was reconstituted into lipid
bilayers lacking cholesterol, agonist cannot stimulate cation
flux. However, the mechanism by which cholesterol regulates
the conformational transitions of the nAChR remains unclear.
Previous hypotheses have postulated two possible mechanisms
to explain the effect of cholesterol on the modulation of AChR
function. The first hypothesis proposes that the action of cho-
lesterol on the nAChR might be associated with the bulk-lipid
bilayer fluidity (9, 11, 13). A second hypothesis suggested that
cholesterol may act as an “allosteric effector” at some non-
annular or interstitial binding sites located within the protein,
which are distinct from the lipid-protein interface (12, 14, 15,
40).
Role of Membrane Lipid Composition on the Conformational
Equilibrium of the nAChR (Fluidity Hypothesis)—In this model
an increase in membrane fluidity (reduced cholesterol) leads to
a shift in nAChR (via an intermediate state) toward the desen-
sitized state (D) (13). This hypothesis is in agreement with our
data from the cholesterol depletion experiments for the Tor-
pedo wild type. However, it does not explain the increase in
macroscopic response observed for the C418W mutation. Why
does a reduction in cholesterol level lead to activation of a
lipid-exposed mutation? For the C418W mutation, the fluidity
model works in the opposite direction. In high fluidity we
observed a higher degree of activation. This increase in macro-
scopic response might be caused by a gain in function response
and/or an increase in the resting (R) pool of nAChR. A very
attractive hypothesis is that the opening transition of the
C418W is facilitated in a more fluid environment due to
penetration of the tryptophan side chain in the bilayer, leading
to a more stable open-channel state. Another hypothesis is that
the equilibrium between resting and desensitized states of the
nAChR is very sensitive to cholesterol levels in the membrane,
and higher cholesterol levels in both cases decrease the active
resting pool of receptors. It is also remarkable that the C418W
mutation recovered from the inhibitory effect at high levels of
cholesterol when the C/P molar ratio was restored close to the
normal value. In contrast, the wild type did not recover from
the inhibitory effects at high levels of cholesterol. Therefore,
substitution of a tryptophan side chain at a single lipid-exposed
mutation produced an nAChR that is much more sensitive to
cholesterol than the wild type receptor. The present data sug-
gest that the mechanism by which cholesterol modulates AChR
function might involve specific structural interactions or per-
haps specific orientations of the transmembrane domains that
are exposed toward the lipid environment. Based on the esti-
mation of the energetic contribution of the tryptophan side
chain to the closing channel rate, one of the hypotheses was
that a tryptophan could interact with the lipid interface via
Van der Waals or dipole interactions at the periphery of the
nAChR. Based on this hypothesis and the present data, it is
reasonable to speculate that the tryptophan residue at position
C418 could be altering normal interactions of the nAChR with
cholesterol leading to the observed increase in sensitivity to the
membrane cholesterol levels. Along this line of thinking, future
studies with different side chains at the C418 will be needed
to define the functional role of these interactions. The present
data suggest that the dramatic differences in the functional
modulation of cholesterol that we observed between the Tor-
pedo wild type and the C418W mutation are governed by
specific interactions of the lipid-exposed domains of the nAChR
with the membrane lipid bilayer.
Conclusions—In summary, the present work represents a
new approach to elucidate the molecular mechanisms of the
interaction of cholesterol with the nAChR. The present data
suggest that cholesterol may be acting on the Torpedo wild type
via a complex regulatory mechanism that controls the equilib-
rium between the silent and functional surface pools of
nAChRs. Further evidence that the movement of receptors
from the silent and functional surface pools of nAChRs is mod-
ulated by membrane lipid composition will represent a novel
mechanism of nAChR regulation. The modulation of cholesterol
on the C418W function is dramatically different from wild
type: 1) at lower cholesterol the C418W shows a gain-in-func-
tion response that could be due to increased levels of nAChRs
or a gain-in-function of channel activity, 2) at high cholesterol
levels higher inhibition is observed, and 3) the inhibition
caused by higher C/P molar ratios could be reversed. Further
experiments at the single channel level will define which of
these mechanisms is responsible for the observed effects on the
C418W. It is conceivable that integral membrane proteins like
the nAChR have an intrinsic bell-shaped response to mem-
brane cholesterol levels and that structural and/or dynamic
interactions at the periphery of the protein-lipid interface can
displace or modulate these bell-shaped profiles to states of
lower or higher activation. Perhaps low levels of side-chain
conservation on the lipid-exposed domains among the nAChR
species have evolved to provide the structural adaptations for
different lipid environments. These new approaches demon-
strate that lipid replacement in oocytes is feasible, and devel-
opment of these methods will open a new avenue to the study
of structural and functional aspects of lipid-protein interac-
tions on ion channel function in a common expression system.
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